DreamCIS, Inc. (223250.KQ) — Stock Score Summary

DreamCIS, Inc. (223250.KQ) has a MoatMap StockRank of 38/100 based on Quality (47/100), Value (47/100), and Momentum (31/100) factor scores. The current signal is HOLD. A South Korean clinical trial management (CRO) firm that lacks the global scale, regulatory footprint, and pricing power of major international CDMO/CRO players.

DreamCIS, Inc. is a leading South Korean contract research organization (CRO) providing comprehensive clinical trial services, post-marketing surveillance, and regulatory affairs consulting to pharmaceutical and biotech firms. Backed by its parent company, Hangzhou Tigermed, DreamCIS possesses a strong competitive moat through its extensive global network and deep regulatory expertise in the Asia-Pacific region. The company is a dominant player in the domestic clinical trial market, facilitating efficient drug development pipelines.

Key Financial Metrics

Price$2.58
Market Cap$78M
P/E (TTM)13.09
P/E (Forward)7.98
Price/Book1.22
Return on Invested Capital12.7%
Debt/Equity18.65
Gross Margin40.9%
Operating Margin3.1%
Revenue Growth22.9%

DreamCIS, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is DreamCIS, Inc.’s (223250.KQ) StockRank?
MoatMap’s StockRank for DreamCIS, Inc. (223250.KQ) is 38/100, with a Hold signal. It is a composite of Quality (47), Value (47), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does DreamCIS, Inc. have an economic moat?
DreamCIS, Inc. (223250.KQ) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is DreamCIS, Inc. a buy, hold, or sell?
MoatMap’s current signal for DreamCIS, Inc. (223250.KQ) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is DreamCIS, Inc. in?
DreamCIS, Inc. (223250.KQ) operates in the Healthcare sector, specifically the Medical Care Facilities industry (South Korea).
Browse all ranked stocks223250.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock